Jan J. Sprengers
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Overcoming treatment implementation barriers for individuals with rare diseases using single-case experimental designs.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: September 12, 2024
CNTN4 modulates neural elongation through interplay with APP.
Journal: Open biology
Published: May 15, 2024
Mechanism-based interventions for ASD cannot be implemented using conventional trial designs.
Journal: Autism research : official journal of the International Society for Autism Research
Published: October 26, 2023
Effects of Bumetanide on Neurocognitive Functioning in Children with Autism Spectrum Disorder: Secondary Analysis of a Randomized Placebo-Controlled Trial.
Journal: Journal of autism and developmental disorders
Published: November 18, 2022
Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study.
Journal: Frontiers in neuroscience
Published: February 19, 2022
Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial.
Journal: Frontiers in psychiatry
Published: September 21, 2021
Prediction of Behavioral Improvement Through Resting-State Electroencephalography and Clinical Severity in a Randomized Controlled Trial Testing Bumetanide in Autism Spectrum Disorder.
Journal: Biological psychiatry. Cognitive neuroscience and neuroimaging
Published: July 01, 2021
Dr. Sprengers et al. Reply.
Journal: Journal of the American Academy of Child and Adolescent Psychiatry
Published: October 12, 2020
Cntn4, a risk gene for neuropsychiatric disorders, modulates hippocampal synaptic plasticity and behavior.
Journal: Translational psychiatry
Published: May 19, 2020
Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial.
Journal: Journal of the American Academy of Child and Adolescent Psychiatry
Published: January 07, 2020
Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics.
Journal: Scientific reports
Published: December 21, 2019
Last Updated: 09/26/2026